MBX Competitors & Alternatives
Compare MBX Biosciences, Inc. Common Stock with similar stocks in the same industry
Biotechnology
MBX
Main Stock$46.39
Tradestie Score
51
Market Cap
$800.41M
Analyst Upside
+48.9%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.16
|
$2.23B | - | 49 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$17.23
|
$2.22B | - | 55 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$55.95
|
$2.21B | - | 64 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$24.77
|
$2.18B | - | 61 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$15.38
|
$2.08B | - | 60 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$17.26
|
$2.02B | 49.7 | 54 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$15.25
|
$2.01B | - | 56 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$36.31
|
$1.97B | - | 63 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$10.12
|
$1.92B | - | 57 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$90.21
|
$1.92B | - | 54 | Compare |
More MBX Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2834)
225 stocks in this industry